Article
Autoantibodies against modified apolipoprotein B-100 in relation to low-density lipoprotein size and the metabolic syndrome in otherwise healthy men.
Metabolism: clinical and experimental - 1 Mar 2008
Sjögren Per, Fredrikson Gunilla N, Rosell Magdalena, de Faire Ulf, Hamsten Anders, Nilsson Jan, Hellenius Mai-Lis, Fisher Rachel M
Abstract excerpt
The role of inflammation in atherosclerotic disease is well established, but the role of autoantibodies against modified apolipoprotein (apo) B-100 remains unclear. The metabolic syndrome is associated with a proinflammatory state, a predominance of small dense low-density lipoprotein (LDL) particles, and an increased risk for atherosclerotic diseases. Previous studies have shown specific autoantibodies against...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.